Growing Evidence and Remaining Questions in Adolescent Transgender Care

This week in the Journal , a much-awaited primary report from Chen et al. 1 on 2 years of gender-affirming hormones (GAH) in transgender adolescents appears. The approach to adolescent transgender care with early treatment with puberty blockers, and GAH in youth from 16 years of age, originated in t...

Ausführliche Beschreibung